» Articles » PMID: 26647961

Dendritic Cells Pulsed with Hsp70 and HBxAg Induce Specific Antitumor Immune Responses in Hepatitis B Virus-associated Hepatocellular Carcinoma

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2015 Dec 10
PMID 26647961
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have drawn attention to dendritic cell (DC) vaccines; particularly the application of the tumor-associated antigen-targeted DC vaccine. The present study analyzed DCs derived from a normal individual and pulsed the cells with heat shock protein 70 peptide (Hsp70) and/or hepatitis B virus x antigen (HBxAg), a hepatocellular carcinoma (HCC)-associated antigen. It was then investigated whether this method of vaccination induced strong therapeutic antitumor immunity. The results revealed that the Hsp70/HBxAg complex-activated phenotype improves the functional maturation of DCs compared with using Hsp70 or HBxAg alone. Compared with either Hsp70 or HBxAg alone, matured DCs pulsed with the Hsp70/HBxAg complex stimulated a high level of autologous T-cell proliferation and induced HCC-specific cytotoxic T lymphocytes, which specifically killed HCC cells through a major histocompatibility complex class I mechanism. These results indicated that a vaccination therapy using DCs co-pulsed with the Hsp70/HBxAg complex is an effective strategy for immunotherapy and may offer a useful approach to protect against HCC.

Citing Articles

Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC.

Khan M, Mao B, Hu J, Shi M, Wang S, Ur Rehman A Front Immunol. 2024; 15:1472430.

PMID: 39450177 PMC: 11499146. DOI: 10.3389/fimmu.2024.1472430.


Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy.

Chen Y, Tang S, Cai F, Wan Y Research (Wash D C). 2024; 7:0421.

PMID: 39040921 PMC: 11260559. DOI: 10.34133/research.0421.


Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.

de Beijer M, Jansen D, Dou Y, van Esch W, Mok J, Maas M J Virol. 2019; 94(7).

PMID: 31852786 PMC: 7081907. DOI: 10.1128/JVI.01663-19.


Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.

Wang X, Wang Q Can J Gastroenterol Hepatol. 2018; 2018:9049252.

PMID: 29805966 PMC: 5899840. DOI: 10.1155/2018/9049252.

References
1.
Harty J, Tvinnereim A, White D . CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol. 2000; 18:275-308. DOI: 10.1146/annurev.immunol.18.1.275. View

2.
Cassel J, Ilyin S, McDonnell M, Reitz A . Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ. Bioorg Med Chem. 2012; 20(11):3609-14. DOI: 10.1016/j.bmc.2012.03.067. View

3.
Ibrahim S, Lewandowski R, Sato K, Gates V, Kulik L, Mulcahy M . Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol. 2008; 14(11):1664-9. PMC: 2695906. DOI: 10.3748/wjg.14.1664. View

4.
Gautam P, Kumar S, Deepak P, Acharya A . Morphological effects of autologous hsp70 on peritoneal macrophages in a murine T cell lymphoma. Tumour Biol. 2013; 34(6):3407-15. DOI: 10.1007/s13277-013-0913-x. View

5.
Wang Z, Zhang G, Wu J, Jia M . Adjuvant therapy for hepatocellular carcinoma: current situation and prospect. Drug Discov Ther. 2013; 7(4):137-43. View